Newsroom

Sorted by: Latest

-

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an investigational, potential first-in-class integrin beta-6 (IB6) directed antibody-drug conjugate (ADC). The study enrolled adults with locally advanced, unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) who had received one or more lines of prior therapy. In the overall population, sigvo...
-

Guardian Pharmacy Services, Inc. Announces Leadership Transitions

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes’s retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris’ new role, Will Mudd, Senior Vice President, Finance, has b...
-

Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana’s Investor Relations page at h...
-

Qnity Powers the Transition from Shrink to Stack with Advanced Packaging Solutions

WILMINGTON, Del.--(BUSINESS WIRE)--Qnity Electronics, Inc. (“Qnity”) (NYSE: Q), a premier technology solutions leader across the semiconductor value chain, today announced the launch of its Advanced Packaging Innovation Hub, underscoring advanced packaging as a strategic growth driver and innovation priority for the company. The new online platform showcases Qnity’s breadth of material and technology solutions designed for advanced packaging, enabling the next generation of artificial intellige...
-

Murphy Oil Corporation Announces Oil Discovery at Bubale-1X Offshore Côte d'Ivoire

HOUSTON--(BUSINESS WIRE)--Murphy Oil Corporation (NYSE: MUR) today announced an oil discovery at the Bubale-1X exploration well in Block CI-709, located approximately 40 miles offshore Côte d’Ivoire. The Bubale-1X well was drilled to a total depth of 20,548 feet (6,263 meters) in 7,795 feet (2,376 meters) of water. The well encountered 100 feet (30 meters) of net oil pay across two reservoirs, with preliminary assessment indicating high-quality light oil. “Early results at Bubale reinforce the...
-

Nakamoto Announces Closing of Legacy Healthcare Clinics

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (Nasdaq: NAKA) (“Nakamoto” or the “Company”) today announced that its healthcare clinics concluded operations on June 19, 2026. Additional administrative activities associated with the wind-down of the Company’s legacy healthcare business are expected to be completed in the third quarter of 2026.The clinic closure reflects the Company’s full transition to a Bitcoin operating company focused on media & information services, asset management &am...
-

Samenvatting: HistoSonics maakt een financiering bekend met deelname van Yosemite naast andere strategische investeerders

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, de ontwikkelaar van het Edison® Histotripsy System en nieuwe platformen voor histotripsietherapie, maakte vandaag de afronding bekend van een nieuwe financieringsronde met deelname van Reed Jobs en Yosemite, die ernaar streven om “kanker niet-dodelijk in onze levensloop te maken”, samen met verschillende nieuwe strategische investeerders. Er werden geen andere financiële voorwaarden bekendgemaakt. Deze financiering komt op een belangrijk momentum voor...
-

Korn Ferry Board Declared Quarterly Cash Dividend

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY), a global consulting firm, today announced its Board of Directors has declared a cash dividend of $0.55 per share that will be payable on July 31, 2026 to shareholders of record on July 6, 2026. “We are pleased to announce another quarterly cash dividend,” said Gary D. Burnison, CEO, Korn Ferry. “This decision underscores the strength and resilience of our business. Also reflecting our continued commitment to a balanced approach to capital all...
-

Comfort Systems Announces Leadership Transitions and Appointments Effective as of July 1, 2026

HOUSTON--(BUSINESS WIRE)--Comfort Systems USA, Inc. (NYSE: FIX) (the “Company”), a leading provider of commercial, industrial and institutional heating, ventilation, air conditioning and electrical contracting services, today announced that Craig Sasser, currently Regional Vice President – Atlantic Region, will be appointed to serve as Chief Operating Officer, effective July 1, 2026. Trent T. McKenna will continue to serve as President of the Company. Mr. Lane commented, “I’m thrilled to congra...
-

ヒストソニックス、ヨセミテ(Yosemite)などの戦略的投資家が参加する資金調達を発表

ミネアポリス--(BUSINESS WIRE)--(ビジネスワイヤ) -- 「Edison®ヒストトリプシー・システム」および新しいヒストトリプシー治療プラットフォームを開発するヒストソニックスは、「私たちが生きている間に、がんを命に関わらない病気にする」ことを目指すリード・ジョブズ(Reed Jobs)氏およびヨセミテ(Yosemite)、ならびに複数の新たな戦略的投資家が参加する新たな資金調達ラウンドを完了したことを発表しました。資金調達に関するその他の条件は開示されていません。 今回の資金調達は、ヒストソニックスの勢いが大きく高まる中で実施されたもので、同社は世界各地で肝腫瘍に対するヒストトリプシーの臨床導入を引き続き拡大するとともに、各種固形腫瘍に対する非侵襲的プラットフォームの追加応用を急速に進めています。 「時代を代表する企業を築くには、資本の提供にとどまらないパートナーが必要です」と、ヒストソニックスの会長兼最高経営責任者(CEO)であるマイク・ブルーは述べました。「今回の資金調達により、当社の使命を理解し、今後広がる大きな機会を認識するとともに、患者、医師、株主に持続...